Winston & Strawn represented HealthCare Royalty Partners (HCRx) in the sale of a majority interest to KKR, a global investment firm offering alternative asset management. Moving forward, HCRx will work with KKR to deliver financing solutions to global biopharma companies.
The Winston & Strawn team was led by Partner Benjamin Kern.







